Cantel Medical Corp. (NYSE:CMN) shares reached a new 52-week high on Monday . The stock traded as high as $77.17 and last traded at $77.16, with a volume of 119,200 shares changing hands. The stock had previously closed at $75.95.

CMN has been the subject of several research analyst reports. Benchmark Co. initiated coverage on shares of Cantel Medical Corp. in a report on Monday, August 29th. They issued a “buy” rating and a $83.00 price target for the company. Needham & Company LLC initiated coverage on shares of Cantel Medical Corp. in a report on Wednesday, August 24th. They issued a “hold” rating for the company.

The firm has a market capitalization of $3.19 billion and a price-to-earnings ratio of 56.44. The company has a 50-day moving average of $70.31 and a 200 day moving average of $68.73.

Cantel Medical Corp. (NYSE:CMN) last posted its earnings results on Wednesday, June 8th. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.36 by $0.08. During the same quarter in the prior year, the business earned $0.35 earnings per share. The business had revenue of $173.70 million for the quarter, compared to analyst estimates of $163.16 million. The firm’s quarterly revenue was up 22.8% on a year-over-year basis. On average, equities analysts forecast that Cantel Medical Corp. will post $1.43 EPS for the current fiscal year.

In other Cantel Medical Corp. news, COO Jorgen B. Hansen sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 15th. The shares were sold at an average price of $72.44, for a total transaction of $144,880.00. Following the completion of the transaction, the chief operating officer now owns 41,383 shares in the company, valued at approximately $2,997,784.52. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Eric W. Nodiff sold 2,574 shares of the firm’s stock in a transaction that occurred on Friday, June 10th. The stock was sold at an average price of $72.97, for a total transaction of $187,824.78. Following the transaction, the executive vice president now owns 53,084 shares of the company’s stock, valued at approximately $3,873,539.48. The disclosure for this sale can be found here.

Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.